Retracted: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors is a dataset published in Neuro-Oncology (2022). On theSindex it has a DataRank of 0.588, placing it in the top 33.5% of the data-sharing corpus. It has been cited 8 times, with 8 citing works in its 1-hop citation network.
Ranks in the top 33% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.258
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
National Institutes of Health
Grant: U01CA168397
National Institutes of Health
Grant: R01NS080939
NCI NIH HHS
Grant: T32 CA067754
NIGMS NIH HHS
Grant: T32 GM007198
NCI NIH HHS
Grant: U19 CA264512
National Brain Tumor Society
FWCI
0.63
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals